Business Context and Reporting Period
This Form 6-K filing by Coca-Cola Europacific Partners Plc was submitted on March 14, 2023. The report serves as a notification of transactions involving Persons Discharging Managerial Responsibilities (PDMR) and persons closely associated with them (PCA). The filing details the grant of Performance Share Units (PSUs) under the Company's Long-Term Incentive Plan 2016 to various senior executives and general managers.
Key Financial Metrics
The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory disclosure regarding executive compensation awards.
- Instrument Type: Performance Share Units (PSUs) in Ordinary Shares (€0.01 each).
- Transaction Price: USD $0 (Grant of awards).
- Total Volume Disclosed: 114,772 Ordinary Shares (aggregate of all listed transactions).
- Vesting Date: March 13, 2026 (subject to continued service and performance conditions).
Material Changes
The filing does not contain comparative financial data or material changes to the company's business operations versus prior periods. It reports a single event: the initial notification of PSU grants executed on March 13, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary contingency noted is that the PSUs are subject to continued service and the satisfaction of applicable performance conditions to vest on March 13, 2026. All transactions were conducted off-market (outside of a trading venue).
Important Facts for Investors
- Executive Awards: Significant PSU grants were made to the CEO (Damian Gammell, 65,369 shares) and CFO (Manik Jhangiani, 28,679 shares), representing the largest individual allocations in this filing.
- Scope of Recipients: Awards were distributed across 15 individuals, including the CEO, CFO, General Counsel, and General Managers for key regions (Northern Europe, Germany, France, Great Britain, Australia/Pacific/Indonesia).
- Cost to Company: The grants were made at a price of $0, representing a future equity liability contingent on performance.
- Regulatory Compliance: This filing satisfies disclosure requirements under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 regarding PDMR transactions.